Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.810
+0.030 (1.69%)
At close: May 13, 2025, 4:00 PM
1.800
-0.010 (-0.55%)
Pre-market: May 14, 2025, 5:22 AM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.00 million as of May 14, 2025. Its market cap has decreased by -32.31% in one year.
Market Cap
1.00M
Enterprise Value
-3.06M
1-Year Change
-32.31%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $1.00M, a decrease of -98.51%. That is a compound annual growth rate of -69.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 986.14K | -62.34% |
| Dec 31, 2024 | 2.62M | 73.26% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |